We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ubiquitin Ligase Protects Against Autoimmune Disease

By Biotechdaily staff writers
Posted on 12 Sep 2004
Researchers have found that the ubiquitin ligase Cbl-b plays a critical role in preventing the development of arthritis and other autoimmune diseases.

Ubiquitin (Ub) is a small protein composed of 76 amino acids. More...
This protein is found in all cells of eukaryotic organisms. Ubiquitin is highly conserved, meaning that the amino acid sequence does not differ much when very different organisms are compared. For example, there are only three differences in the sequence when Ub from yeast is compared to human Ub. This strong sequence conservation suggests that the vast majority of amino acids that make up Ub are essential, as apparently any mutations that have occurred over evolutionary history have been removed by natural selection.

Ubiquitin becomes attached covalently to certain residues of other proteins. The attachment of a chain of ubiquitins tags a protein for intracellular proteolytic destruction. Ubiquitin ligases are a class of enzymes that determines the substrate protein to which a ubiquitin will be linked and that binds the ubiquitin to this protein. Many ubiquitin ligases are multi-subunit proteins.

In the current study, investigators from the La Jolla Institute for Allergy and Immunology (San Diego, CA, USA) and the Institute for Molecular Biotechnology of the Austrian Academy of Sciences (Vienna, Austria) worked with mice genetically engineered to lack the gene for Cbl-b. These mice as well as a normal control group were injected with substances known to induce arthritis. Results reported in the August 2004 issue of Immunity revealed that while the normal mice did not respond to the injection, the mice lacking Cbl-b developed severe symptoms of arthritis.
"We concluded that the Cbl-b molecule was affecting the T cell's immune response, giving the immune system of the normal mice the ability to ‘tolerate' the arthritis antigens,” explained contributing author Dr. Yun-Cai Liu, a researcher at the La Jolla Institute for Allergy and Immunology. "The mice without the Cbl-b molecule could not tolerate these substances and their T cells began attacking their own tissues, leading to the development of the autoimmune disease.”

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.